Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?

Aortic valve stenosis remains the most frequent structural heart disease, especially in the elderly. During the last decade, we noticed an important consideration and a huge number of publications related to the medical and surgical treatment of this disease. However, the molecular aspect of this de...

Full description

Bibliographic Details
Main Authors: Joseph Nader, Laurent Metzinger, Pierre Maitrias, Thierry Caus, Valérie Metzinger-Le Meuth
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2020-06-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054020300160
_version_ 1797205221632376832
author Joseph Nader
Laurent Metzinger
Pierre Maitrias
Thierry Caus
Valérie Metzinger-Le Meuth
author_facet Joseph Nader
Laurent Metzinger
Pierre Maitrias
Thierry Caus
Valérie Metzinger-Le Meuth
author_sort Joseph Nader
collection DOAJ
description Aortic valve stenosis remains the most frequent structural heart disease, especially in the elderly. During the last decade, we noticed an important consideration and a huge number of publications related to the medical and surgical treatment of this disease. However, the molecular aspect of this degenerative issue has also been more widely studied recently. As evidenced in oncologic but also cardiac research fields, the emergence of microRNAs in the molecular screening and follow-up makes them potential biomarkers in the future, for the diagnosis, follow-up and treatment of aortic stenosis. Herein, we present a review on the implication of microRNAs in the aortic valve disease management. After listing and describing the main miRNAs of interest in the field, we provide an outline to develop miRNAs as innovative biomarkers and innovative therapeutic strategies, and describe a groundbreaking pre-clinical study using inhibitors of miR-34a in a pre-clinical model of aortic valve stenosis.
first_indexed 2024-04-24T08:47:41Z
format Article
id doaj.art-86a0dd00b2d546b3beafacdfd8499ba9
institution Directory Open Access Journal
issn 2468-0540
language English
last_indexed 2024-04-24T08:47:41Z
publishDate 2020-06-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj.art-86a0dd00b2d546b3beafacdfd8499ba92024-04-16T12:57:24ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402020-06-01524147Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?Joseph Nader0Laurent Metzinger1Pierre Maitrias2Thierry Caus3Valérie Metzinger-Le Meuth4Department of Cardiac Surgery, Amiens University Hospital, Amiens, France; Corresponding author. Department of Cardiac Surgery, Amiens University Hospital, Amiens, Av. René Laennec, 80054, Amiens France.HEMATIM EA4666, C.U.R.S, Université de Picardie Jules Verne, 80025, AMIENS Cedex 1, FranceDepartment of Vascular Surgery, Polyclinique Saint Côme, Compiègne, FranceDepartment of Cardiac Surgery, Amiens University Hospital, Amiens, FranceHEMATIM EA4666, C.U.R.S, Université de Picardie Jules Verne, 80025, AMIENS Cedex 1, France; INSERM U1148, Laboratory for Vascular Translational Science (LVTS), UFR SMBH, Université Paris 13-Sorbonne Paris Cité, 93017, BOBIGNY CEDEX, FranceAortic valve stenosis remains the most frequent structural heart disease, especially in the elderly. During the last decade, we noticed an important consideration and a huge number of publications related to the medical and surgical treatment of this disease. However, the molecular aspect of this degenerative issue has also been more widely studied recently. As evidenced in oncologic but also cardiac research fields, the emergence of microRNAs in the molecular screening and follow-up makes them potential biomarkers in the future, for the diagnosis, follow-up and treatment of aortic stenosis. Herein, we present a review on the implication of microRNAs in the aortic valve disease management. After listing and describing the main miRNAs of interest in the field, we provide an outline to develop miRNAs as innovative biomarkers and innovative therapeutic strategies, and describe a groundbreaking pre-clinical study using inhibitors of miR-34a in a pre-clinical model of aortic valve stenosis.http://www.sciencedirect.com/science/article/pii/S2468054020300160Aortic stenosismicroRNATranslational researchBiomarker
spellingShingle Joseph Nader
Laurent Metzinger
Pierre Maitrias
Thierry Caus
Valérie Metzinger-Le Meuth
Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
Non-coding RNA Research
Aortic stenosis
microRNA
Translational research
Biomarker
title Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
title_full Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
title_fullStr Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
title_full_unstemmed Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
title_short Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
title_sort aortic valve calcification in the era of non coding rnas the revolution to come in aortic stenosis management
topic Aortic stenosis
microRNA
Translational research
Biomarker
url http://www.sciencedirect.com/science/article/pii/S2468054020300160
work_keys_str_mv AT josephnader aorticvalvecalcificationintheeraofnoncodingrnastherevolutiontocomeinaorticstenosismanagement
AT laurentmetzinger aorticvalvecalcificationintheeraofnoncodingrnastherevolutiontocomeinaorticstenosismanagement
AT pierremaitrias aorticvalvecalcificationintheeraofnoncodingrnastherevolutiontocomeinaorticstenosismanagement
AT thierrycaus aorticvalvecalcificationintheeraofnoncodingrnastherevolutiontocomeinaorticstenosismanagement
AT valeriemetzingerlemeuth aorticvalvecalcificationintheeraofnoncodingrnastherevolutiontocomeinaorticstenosismanagement